Liposomal and Lipid Nanoparticle (LNP) Drug Delivery Systems Market continues to gain momentum, reaching a valuation of USD 5.08 billion in 2024 and projected to expand to USD 10.34 billion by 2031, exhibiting an impressive CAGR of 10.8% during the forecast period. This strong market trajectory underscores the growing importance of lipid-based delivery technologies in modern therapeutics,...